Pharmacogenomics in Asian Subpopulations and Impacts on Commonly Prescribed Medications
Asians as a group comprise > 60% the world's population. There is an incredible amount of diversity in Asian and admixed populations that has not been addressed in a pharmacogenetic context. The known pharmacogenetic differences in Asian subgroups generally represent previously known variant...
Saved in:
Main Authors: | Cody Lo (Author), Samantha Nguyen (Author), Christine Yang (Author), Lana Witt (Author), Alice Wen (Author), T. Vivian Liao (Author), Jennifer Nguyen (Author), Bryant Lin (Author), Russ B. Altman (Author), Latha Palaniappan (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: State of the science of pharmacogenomics implementation in healthcare systems and communities
by: Sean P. David, et al.
Published: (2024) -
Analysis of Comprehensive Pharmacogenomic Profiling of VIP Variants Among the Genetically Isolated Chechen Subpopulation from Jordan
by: AL-Eitan LN, et al.
Published: (2020) -
The association between Asian patient race/ethnicity and lower satisfaction scores
by: Lillian Liao, et al.
Published: (2020) -
Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit
by: Shuqin Zhou, et al.
Published: (2018) -
Vaccination patterns, disparities, and policy among Asian-Americans and Asians living in the USA
by: Armaan Jamal, et al.
Published: (2022)